Are SJW and moclobemide the only antidepressant supplement/drug you've tried? Have you tried taking an antidepressant for for a full 2-3 month trial to determine whether you benefit from whatever mysterious combination of neurogenesis, receptor downregulation, neurosteroid alteration, or endocrine-system changes that are theorized to occur with anti-depressant drugs, but which are theorized to only occur to a significant degree over time?
I also only experience the desirable effects of antidepressants in the start-up phase, I get worse and worse on the drugs past 10 days or so and they don't "kick in" after 2-3 months for me, and I have a neurobabble hypothesis as to why: those who don't have things like an atrophied hippocampus, upregulated monoamine receptors or transporters, or hypercortisolemia, won't get any benefits from antidepressants beyond the initial and temporary disruption in neurotransmitter homeostasis. If your monoamines receptors or transporters are already downregulated for whatever unique genetic or epigenetic reason, you will probably get some desirable effects from increased monoamine release or transporter blockade in the short term, but homeostasis or baseline will inevitably happen and the pre-existing problem only get worse as the brain downregulates receptors and upregulates transporters in response.
SSRIs, ADHD meds, venlafaxine, buproprion, selegiline at purported MAO-A inhibitory doses, 5-HTP and SJW all have desirable start up effects but just leave me worse off than baseline with extended use. I say "neurobabble" here because these ideas are not specifically proven at this time, and not provable because its not possible to measure neurotransmitters accurately in a living human. There hasn't been much research into how people with already high or downregulated neurotransmitter systems react to antidepressants because how do you even prove that inclusion criteria?
Edited by Dichotohmy, 16 August 2017 - 09:50 PM.